Healthcare currently experiences profound changes through artificial intelligence (AI), evidence-based medicine, and personalized treatments, along with new home-based care models. Dr. Sam Sater leads a global patient care transformation as the founder of HAS Consulting and NOVORÊX through his visionary model.

From Adversity to Innovation

Dr. Sater achieved breakthrough discoveries through his individual life experiences. Through the process of overcoming major childhood traumas, he dedicated himself to helping others succeed. Dr. Sater established NOVORÊX by dedicating his deep study to medicine and psychology, along with holistic health concepts that base healing methods on evidence-backed holistic treatments and build individual resilience through empowerment techniques.

Turning pain into purpose, he studied his career in healing and immersed himself in hundreds of books across multiple disciplines. He discovered a powerful combination of mindset, knowledge, and compassion behind his success in helping many patients, including those with advanced-stage cancer, achieve healing. This became the foundation for NOVORÊX, a method that empowers doctors, nurses, and patients alike through belief, resilience, and a deeply humane approach.

HAS Consulting: AI-Powered Medicine for Smarter Healthcare

Dr. Sater uses HAS Consulting to develop the biggest AI-powered medical platform that enables experts to edit AI data from ChatGPT and DeepSeek through neural network supervision. arranty-based medicine consumes thousands of cases for its decisions, whereas this novel system employs millions of cases to generate evolving real-time medical data.

The platform sticks to an approach centered around human interactions. The AI system works alongside healthcare personnel to support diagnosis activities, yet stays behind their expertise and clinical experience as the central decision-making force. NOVORÊX-trained humanized AI models process and enhance multidisciplinary knowledge from basic and clinical sciences through psychology and sociology, and behavioral science disciplines.

Recent studies have already shown that AI can accurately detect cancers on par with top doctors. In mammography, AI achieved a sensitivity of 85%, compared to 77% for radiologists, and improved diagnostic accuracy overall, with a pooled AUC of 0.89 versus 0.82 for human experts. In addition, AI-assisted colonoscopies increased adenoma detection rates by 20%, a measure linked to a reduction in colorectal cancer mortality. Tools like Stanford’s MUSK model and IBM Watson Oncology demonstrate AI’s capacity to stratify cancer risk and recommend treatments with high concordance to tumor boards.

AI also supports faster treatment decisions. In the UK, the NHS has adopted AI solutions that analyze scans up to 2.5 times faster than doctors, accelerating the time from diagnosis to treatment. Oncology-specific tools also optimize radiotherapy planning, saving clinicians hours per patient.

The platform will utilize the most up-to-date and innovative preventive, diagnostic, and therapeutic approaches, and track patient outcomes, including quality of life and longevity, to ensure the highest standard of care. This visionary approach is poised to revolutionize healthcare, bridging the gap between artificial intelligence and human expertise to provide the most precise, personalized, and effective treatments.

NOVORÊX: A Paradigm Shift in Patient Care

NOVORÊX is a revolutionary healing method that breaks the traditional model of burnout for doctors and helplessness for patients. Instead, it instills a powerful mindset rooted in:

  • The Power of Human Connection
  • The Power of Safety and Trust
  • The Power of Knowledge
  • The Power of Choice and Autonomy
  • The Power of Positivity and Belief

Through NOVORÊX Academy, these principles are continuously refined using research from psychology, sociology, and neuroscience, and applied in real-world patient care to build newer, updated versions of the method. Additionally, humanized AI models using the Novorex method leverage AI to summarize and refine knowledge across various health-related disciplines, all to enhance patient care holistically.

Bringing Healthcare Home: Enhancing Outcomes, Reducing Costs

One of the most groundbreaking aspects of Dr. Sater’s vision is the belief that medicine should be a direct service delivered to the home. HAS Consulting’s home-based care model minimizes hospital visits, reduces travel burdens for patients and families, and upholds patient dignity.

Using advanced tools like mobile X-rays, ultrasound, and novel IV bags, care is administered by NOVORÊX-certified professionals. Studies and feasibility models show that even advanced cancer patients treated at home report improved quality of life and extended survival. A study of 2,878 patients with advanced cancer found that those receiving home-based palliative care lived significantly longer, 65 days, compared to 32 in the hospital. Another showed a median survival of 67 vs. 33 days for home hospice vs. hospital-based care. Additionally, 90% of patients preferred future treatment at home over therapy in a hospital or institutional setting.

Economic and Social Implications

The HAS/NOVORÊX model offers significant financial advantages by moving away from traditional hospital-centered care. This shift has the potential to save billions in healthcare and insurance costs by:

  • Reducing reliance on costly hospital infrastructure and overhead
  • Eliminating inflated pharmaceutical markups common in hospital systems
  • Enabling millions of patients to receive care at home, thereby cutting down on travel, emissions, and system strain

Evidence supports these economic claims. In-home palliative care models have shown cost savings of 30–50%. A 10% shift of end-of-life patients to home care saved ~$9 million annually in Ontario. The U.S. Veterans Health Administration saw 24% lower costs for home-based primary care. The Huntsman Cancer Institute reported 55% fewer hospitalizations and 45% fewer ER visits for home-treated cancer patients.

AI adds further value by preventing overtreatment, accelerating diagnoses, and optimizing care to increase cost-effectiveness per QALY. This efficient, human-centered model may save billions across healthcare and insurance systems while delivering better outcomes.

NOVORÊX Academy will serve as a hub for academic research, studying the financial and social impacts of this new healthcare model while refining its approach based on real-world data and patient outcomes.

A Call to Action: Join the Revolution

Dr. Sater’s work represents more than healthcare innovation — it embodies a shift toward greater human dignity, financial efficiency, and social impact. By embracing an integrated model of AI, personalized medicine, and holistic home care, the healthcare sector can significantly improve patient experiences worldwide.

By combining transparent, explainable AI with compassionate human oversight, HAS Consulting ensures that technology enhances — not replaces — the therapeutic alliance between doctors and patients.

Discover Dr. Sater’s groundbreaking work and his visionary approach to the future of medicine on NOVORÊX’s website.